Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Capital Expenditures Growth (1y) (2021 - 2026)

Analysis

Praxis Precision Medicines (PRAX) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 39.02%
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 30.84%
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn -22.99%
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 9.68%
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 1,133.33%
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 142.64%
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 53.76%
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.13%
Sep 30, 2023 11.11%
Sep 30, 2022 -89.68%
Jun 30, 2022 243.75%
Mar 31, 2022 466.67%
Dec 31, 2021 13,175.00%
API Access

Praxis Precision Medicines Capital Expenditures Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures-growth-1y&ticker=PRAX&period=max&api_key=YOUR_API_KEY